These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 6137575
1. [Neuromuscular and circulatory effect of NC45 in rats]. Amaki Y, Wada T, Koyama T, Tanak K, Kobayashi K. Masui; 1983 Jun; 32(6):737-41. PubMed ID: 6137575 [No Abstract] [Full Text] [Related]
2. [The interaction between vecuronium (NC 45) and pancuronium or d-tubocurarine in the rat phrenic nerve-hemidiaphragm preparation]. Amaki Y, Koyama T, Tanaka K, Kobayashi K. Masui; 1984 Oct; 33(10):1137-40. PubMed ID: 6151603 [No Abstract] [Full Text] [Related]
3. [Evaluation of neuromuscular blocking and circulatory effects of vecuronium bromide and pancuronium bromide by a double blind study]. Sugai N, Inada Y, Goto Y, Hashimoto Y, Kaya K, Suzuki H, Iwai S, Murakami S, Kosaka F, Ebihara A. Masui; 1986 Apr; 35(4):563-71. PubMed ID: 2875196 [No Abstract] [Full Text] [Related]
4. Neuromuscular and vagal blocking actions of pancuronium bromide, its metabolites, and vecuronium bromide (Org NC45) and its potential metabolites in the anaesthetized cat. Marshall IG, Gibb AJ, Durant NN. Br J Anaesth; 1983 Aug; 55(8):703-14. PubMed ID: 6136285 [Abstract] [Full Text] [Related]
5. A comparison of the neuromuscular blocking and vagolytic effects of ORG NC45 and pancuronium. Son SL, Waud BE, Waud DR. Anesthesiology; 1981 Jul; 55(1):12-8. PubMed ID: 6113793 [Abstract] [Full Text] [Related]
6. Neuromuscular blocking action of vecuronium in the dog and its reversal by neostigmine. Jones RS. Res Vet Sci; 1985 Mar; 38(2):193-6. PubMed ID: 2860709 [Abstract] [Full Text] [Related]
7. [The clinical evaluation of Org-NC45 in pediatric anaesthesia]. Obara H, Hoshina H, Chuma R, Tanaka O, Morikawa S, Iwai S. Masui; 1985 Jun; 34(6):799-804. PubMed ID: 2863399 [No Abstract] [Full Text] [Related]
9. Hypothermic cardiopulmonary bypass and neuromuscular blockade by pancuronium and vecuronium. Buzello W, Schluermann D, Schindler M, Spillner G. Anesthesiology; 1985 Feb; 62(2):201-4. PubMed ID: 2857541 [No Abstract] [Full Text] [Related]
10. [Pharmacokinetics and pharmacodynamics of vecuronium in children]. Steinbereithner K, Fitzal S, Schwarz S, Gilly H, Semsroth M, Weindlmayr-Goettel M. Cah Anesthesiol; 1984 Feb; 32(1):5-10. PubMed ID: 6152193 [Abstract] [Full Text] [Related]
11. [A comparative study of atracurium, vecuronium and pancuronium using the rat phrenic nerve diaphragm preparation]. Fukushima K, Aoki T, Ishikawa J. Masui; 1985 Jan; 34(1):66-70. PubMed ID: 2860258 [No Abstract] [Full Text] [Related]
14. Clinical pharmacology of ORG NC45 (NorcuronTM): a new nondepolarizing muscle relaxant. Fahey MR, Morris RB, Miller RD, Sohn YJ, Cronnelly R, Gencarelli P. Anesthesiology; 1981 Jul; 55(1):6-11. PubMed ID: 6113794 [Abstract] [Full Text] [Related]
15. Heart rate and blood pressure changes after ORG NC45 (vecuronium) and pancuronium during halothane and enflurane anesthesia. Gregoretti SM, Sohn YJ, Sia RL. Anesthesiology; 1982 May; 56(5):392-5. PubMed ID: 6122389 [No Abstract] [Full Text] [Related]
16. Comparison of the pharmacology and vecuronium and atracurium with that of other currently available muscle relaxants. Hilgenberg JC. Anesth Analg; 1983 May; 62(5):524-31. PubMed ID: 6132564 [No Abstract] [Full Text] [Related]
17. [Pharmacokinetics and pharmacodynamics of vecuronium and pancuronium in anesthetized man]. Yajima C, Sugai N, Inada Y. Masui; 1985 Sep; 34(9):1245-51. PubMed ID: 2868137 [No Abstract] [Full Text] [Related]